Bleeding and Surgery in Children with Glanzmann Thrombasthenia with and without the Use of Recombinant Factor VII a
暂无分享,去创建一个
U. Göbel | U. Hennewig | H. Laws | U. Göbel | S. Eisert
[1] N. Graf,et al. [Clinical trials and studies of the German Society for Paediatric Oncology and Haematology (GPOH) and the European Directive for the Implementation of Good Clinical Practice in the Conduct of Clinical Trials]. , 2004, Klinische Padiatrie.
[2] K. Khair,et al. The use of recombinant factor VIIa in children with inherited platelet function disorders , 2003, British journal of haematology.
[3] A. Chuansumrit,et al. Recombinant activated factor VII combined with local measures in preventing bleeding from invasive dental procedures in patients with Glanzmann thrombasthenia. , 2003, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[4] M. Peters,et al. Treatment of a Patient with Bernard-Soulier Syndrome and Recurrent Nosebleeds with Recombinant Factor VIIa , 1998, Thrombosis and Haemostasis.
[5] G. Henze,et al. [Concepts of the Society of Paediatric Oncology and Haematology (GPOH) and the German Competence Network in Paediatric Oncology and Haematology for the quality controlled development in paediatric oncology]. , 2004, Klinische Padiatrie.